These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Persistence of antibodies after inactivated hepatitis A vaccines in a comparative study. Goilav C; Zuckerman J; Lafrenz M; Vidor E; Briantais P; Lauwers S; Ratheau C; Benichou G; Zuckerman A J Infect; 1997 Mar; 34(2):158. PubMed ID: 9138144 [No Abstract] [Full Text] [Related]
5. [Vaccination against hepatitis A]. Germanaud J; Causse X Servir; 1994; 42(3):161-4. PubMed ID: 8059246 [No Abstract] [Full Text] [Related]
6. Hepatitis A vaccine. Nalin DR J Occup Environ Med; 1996 Dec; 38(12):1200-1. PubMed ID: 8978510 [No Abstract] [Full Text] [Related]
7. Inactivated candidate vaccines for hepatitis A. André FE; Hepburn A; D'Hondt E Prog Med Virol; 1990; 37():72-95. PubMed ID: 2173850 [No Abstract] [Full Text] [Related]
8. Hepatitis A vaccine. Med Lett Drugs Ther; 1995 Jun; 37(950):51-2. PubMed ID: 7760768 [No Abstract] [Full Text] [Related]
9. [Hepatitis A inoculation]. Jilg W Dtsch Med Wochenschr; 1994 Dec; 119(51-52):1800. PubMed ID: 7736937 [No Abstract] [Full Text] [Related]
10. National Advisory Committee on Immunization (NACI). Statement on the prevention of hepatitis A infections. Can Commun Dis Rep; 1994 Aug; 20(16):133-43. PubMed ID: 7951129 [No Abstract] [Full Text] [Related]
11. Vaccination against hepatitis A virus in French hemophilic children. Rothschild C; Pol S; Mattlinger B; Reijasse D; Torchet MF; Gazengel C Vox Sang; 1995; 69(1):80-1. PubMed ID: 7483502 [No Abstract] [Full Text] [Related]
12. Inactivated hepatitis A virus vaccines. Lemon SM Hepatology; 1992 Jun; 15(6):1194-7. PubMed ID: 1317341 [No Abstract] [Full Text] [Related]
13. [Who in The Netherlands is eligible for immunization with inactivated hepatitis A vaccine?]. Leentvaar-Kuijpers A Ned Tijdschr Geneeskd; 1994 May; 138(19):941-2. PubMed ID: 8196784 [No Abstract] [Full Text] [Related]
15. Anatomy of a trial: a historical view of the Monroe inactivated hepatitis A protective efficacy trial. Werzberger A; Kuter B; Shouval D; Mensch B; Brown L; Wiens B; Lewis J; Miller W; Sitrin R; Provost P J Hepatol; 1993; 18 Suppl 2():S46-50. PubMed ID: 8182273 [TBL] [Abstract][Full Text] [Related]
16. Six years' follow-up after hepatitis A vaccination. Werzberger A; Kuter B; Nalin D N Engl J Med; 1998 Apr; 338(16):1160. PubMed ID: 9547152 [No Abstract] [Full Text] [Related]
18. Analysis of the antibody response in humans with a new inactivated hepatitis A vaccine. Vidor E; Xueref C; Blondeau C; Bajard A; Francon A; Goudeau A; Peyron F; Brasseur P; Zuckerman A Biologicals; 1996 Sep; 24(3):235-42. PubMed ID: 8978923 [TBL] [Abstract][Full Text] [Related]
19. Protection of travelers against Hepatitis A viral infection in developing countries. Arya SC J Travel Med; 1998 Dec; 5(4):228-9. PubMed ID: 9935325 [No Abstract] [Full Text] [Related]
20. Acute hepatitis A in a traveler who had received preexposure inactivated hepatitis A virus vaccine. Kurup A; San LM; Yew WS Clin Infect Dis; 1999 Jun; 28(6):1324-5. PubMed ID: 10451178 [No Abstract] [Full Text] [Related] [Next] [New Search]